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INTRODUCTION
1
:
 
Among the different routes of administration, the oral 
route of administration continues to be the most preferred 
route due to various advantages including ease of 
ingestion, avoidance of pain, versatility and most 
importantly patient compliance. The important drawback 
of tablets and capsules dosage forms for pediatric and 
geriatric patients is being difficulty in swallowing.  
Nearly 35% of the general population, especially the 
elderly patients and children suffer from dysphasia or 
difficulty in swallowing, which results in high incidence of 
noncompliance and ineffective therapy. Swallowing 
problems also are very common in young individuals 
because of their poorly developed muscular and nervous 
systems. Other groups who may experience problems in 
swallowing conventional oral dosage forms are the patients 
with tremors of extremities, mentally ill, developmentally 
disabled, non co-operative patients and patients with 
reduced liquid intake plans or patients suffering from 
nausea. The swallowing problems are also common in 
some cases such as patients with motion sickness, sudden 
episodes of allergic attack or coughing and due to lack of 
water. 
Recent advances in technology have presented viable 
dosage alternative for patients who may have difficulty in 
swallowing tablets or capsules. Traditional tablets and 
capsules administered with an 8-oz. glass of water may be 
inconvenient or impractical for some patients. 
To overcome these problems, formulators have 
considerably dedicated their effort to develop novel drug 
delivery systems (NDDS) which enhance safety and 
efficacy of drug molecule and to achieve better patient 
compliance. One such approach is „Oral dispersible 
Tablets‟, which disintegrate or dissolve in saliva and are 
swallowed without water as tablet disintegrate in mouth, 
this could enhance the clinical effect of drug through 
pregastric absorption from the mouth, pharynx, esophagus. 
This leads to an increase in the bioavailability by avoiding 
first pass liver metabolism. 
 
Figure 1: Consumer Acceptance for ODT 
2 
ABSTRACT: 
Hypertension is very dangerous problem. It may occur any time to elder patients so drugs are available for all the times and 
administered by patients are very easy mode. Normally all drugs are administered by oral route with water or some other 
liquid vehicles. At the time of emergency (for hypertension patients) water may get or not. So, to overcome these problems, 
tablets are to be developed and administered without need of water. The purpose of this research was to develop oral 
disintegrating tablets (ODT) of low bitter hypertensive drugs like Drugx using taste enhancers as a taste masking agents. ODT 
of Drugx were prepared using different superdisintegrants by direct compression method.  Mannitol was used as a diluent. 
Aspartame and Acesulfame Potassium were used for unpleasant taste masked from the Drugx by co sifting and serial of 
blending with other excipients.  The mixed final blend was then compressed into tablets. The formulations were evaluated for 
weight variation, hardness, friability, wetting time, disintegrating time, dissolution, taste evaluation study and in vitro 
dissolution. All the formulation showed low weight variation with different disintegration time and rapid in vitro dissolution. 
The results revealed that the tablets containing taste enhancers(40-45%w/w) had a good palatability for the patients. 
 Keywords: Oral Disintigrating Tablet(ODTs), Superdisintegrants, taste masking, patented technology 
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The centre for drug evaluation and research states an orally 
dissolving tablet to be “A dosage form containing 
medicinal substances, which disintegrates rapidly, usually 
within a matter of seconds, when placed upon tongue.” 
This system is recognized with other synonyms like fast 
dissolving tablets; melt in mouth tablets, porous tablets, 
rapidly disintegrating tablets, quick dissolving, and 
rapimelt tablets. Despite various nomenclatures the 
function and concept of all these Drug Delivery System 
(DDS) is similar. 
Advantages of orally disintegrating tablets are being 
recognized in both industry and academia. Their growing 
importance was underlined recently when the European 
Pharmacopoeia adopted the term Oro-dispersible tablet as 
a “tablet to be placed in the mouth where it disperses 
rapidly before swallowing”. 
 
 
Figure 2: Disintegration of tablet  in mouth3 
 IDEAL CHARACTERISTICS
4,6 
 They should not require water or other liquid at the time 
of administration.  
 Should easily disintegrate and dissolve. 
 Mask or overcome unacceptable taste of drug. 
 They should have high drug loading. 
 They should have pleasant feel in the mouth. 
 They should have negligible or no residue in oral cavity 
after administration 
ADVANTAGES
5
:  
 Ease of administration to patients who refuses to 
swallow a tablet such as pediatrics, geriatric patients 
and psychiatric patients. 
 No need or little water is required to swallow the 
dosage form which is highly convenient feature for 
patients who are traveling and do not have access to 
water. 
 Free of risk of suffocation due to physical obstruction 
when swallowed, thus offering improved safety.  
 Rapid disintegration and absorption of drug, which 
will produce quick onset of action. 
 Quick absorption from the gastro intestinal tract 
improves bioavailability and reduces unwanted effects 
caused by the drugs and also improves patient 
compliance¹. 
  DISADVANTAGES: 
 Most fast dissolving tablets lack the mechanical 
strength common to traditional tablets. Many products 
are very lightweight and fragile requiring them to be 
individually packaged.  
 Due to the formulation of fast dissolving tablets which 
are also more susceptible to    degradation via 
temperature and humidity, some of the newest fast 
dissolving tablet  
 TECHNIQUES USED IN FDT6: 
     Following technologies have been used by various 
researchers to prepare fast   dissolving    tablets: 
 Freeze-Drying or Lyophilization 
 Tablet Molding 
 Spray Drying 
 Sublimation 
 Direct Compression 
 Dry granulation 
 Cotton Candy Process 
 Mass-Extrusion 
 
   1. Freeze-Drying or Lyophilization6: 
Freeze drying is the process in which water is sublimed 
from the product after it is frozen. This technique creates 
an amorphous porous structure that can dissolve rapidly. 
Commonly used excipients with their uses and examples 
employed in manufacturing of fast dissolving tablets using 
Freeze-drying are listed on next page. A typical procedure 
involved in the manufacturing of fast dissolving tablets 
using this technique is mentioned here. The active drug is 
dissolved or dispersed in an aqueous solution of a 
carrier/polymer. The mixture is dosed by weight and 
poured in the wells of the preformed blister packs. The 
trays holding the blister packs are passed through liquid 
nitrogen freezing tunnel to freeze the drug solution or 
dispersion. Then the frozen blister packs are placed in 
refrigerated cabinets to continue the freeze-drying. After 
freeze-drying the aluminum foil backing is applied on a 
blister-sealing machine. Finally the blisters are packaged 
and shipped. 
The freeze-drying technique has demonstrated improved 
absorption and increase in bioavailability. The Zydis 
formulations consist of a drug physically trapped in a 
water-soluble matrix (saccharine mixture and polymer), 
which is freeze dried to produce a product that dissolves 
rapidly when placed in mouth. The ideal candidate for 
Zydis technology should be chemically stable and water 
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insoluble and particle size preferably less than 50 micron. 
Water soluble drugs might form eutectic mixtures and not 
freeze adequately, so dose is limited to 60 mg and the 
maximum drug limit is 400 mg for water insoluble drug as 
large particle sizes might present sedimentation problems 
during manufacture. 
The major disadvantages of lyophilization technique are 
that it is expensive and time consuming; fragility makes 
conventional packaging unsuitable for these products and 
poor stability under stressed conditions.  
 2. Tablet Moulding
4,6
: 
The preparation of fast dissolving tablets using molding 
technology employs water-soluble ingredients so that the 
tablet dissolves completely and rapidly. The active 
ingredients in most cases are absorbed through the 
mucosal lining of the mouth. Molding process is of two 
types i.e. solvent method and heat method. Solvent method 
involves moistening the powder blend with a hydro 
alcoholic solvent followed by compression at low 
pressures in molded plates to form a wetted mass 
(compression molding). The solvent is then removed by 
air-drying. The tablets manufactured in this manner are 
less compact than compressed tablets and possess a porous 
structure that hastens dissolution. 
The heat molding process involves preparation of a 
suspension that contains a drug, agar    and sugar (e.g. 
Mannitol or lactose) and pouring the suspension in the 
blister packaging wells, solidifying the agar at the room 
temperature to form a jelly and drying at 30˚C under 
vacuum. The mechanical strength of molded tablets is a 
matter of great concern. Binding agents, which increase 
the mechanical strength of the tablets, need to be 
incorporated. Taste masking is an added problem to this 
technology.  
3. Spray Drying
6
: 
Spray drying is used in pharmaceutical industries to 
produce highly porous powders. The processing solvent is 
evaporated rapidly by spray drying, which renders the 
product highly porous and thus can be used in 
manufacturing fast dissolving tablets. In this technique, 
gelatin can be used as a supporting agent and as a matrix, 
mannitol as a bulking agent and sodium starch glycolate or 
croscarmellose sodium or crospovidone are used as 
superdisintegrants. Tablets manufactured from the spray-
dried powder have been reported to disintegrate in less 
than 20 seconds in aqueous medium. 
 4. Sublimation: 
The key to rapid disintegration of fast dissolving tablets is 
preparation of a porous structure in the tablet matrix. To 
generate such a porous matrix, volatile ingredients are 
incorporated in the formulation that is later subjected to a 
process of sublimation. Highly volatile ingredients like 
ammonium bicarbonate, ammonium carbonate, benzoic 
acid, camphor, naphthalene, urea, urethane and pthalic 
anhydride may be compressed along with other excipients 
into a tablet. This volatile material is then removed by 
sublimation leaving behind a highly porous matrix. Tablets 
manufactured by this technique have reported to usually 
disintegrate in 10-20 sec. Even solvents like cyclohexane, 
benzene can be used as pore forming agents.  
Vacuum drying technique has been very often used by 
researchers to sublime the volatile ingredients and thus 
maximize the porous structure in the tablet matrix. It is 
likely that a porous hydrophilic matrix will easily pick up 
the disintegrating medium and break quickly.  
5. Direct Compression: 
There was no much attention to the direct compression of 
pharmaceuticals in the previous days (late 1950s). Now a 
days great deal of attention has been given to both product 
and process development. The availability of new 
materials, new forms of old materials and the invention of 
new machinery has allowed the production of tablets by 
simplified and reliable methods. In early 1960‟s, the 
introduction of spray dried lactose (1960) and avicel 
(1964) had changed the tablet manufacturing process and 
opened avenues of direct compression tableting. 
Previously, the word direct compression was used to 
identify the compression of a single crystalline compound 
(i.e. sodium chloride, potassium chloride, potassium 
bromide, etc.) into a compact form without the addition of 
other substances. Current usage of the term direct 
compression is used to define the process by which tablets 
are compressed directly from the powder blends of active 
ingredient/s and suitable excipients. No pre-treatment of 
the powder blends by wet or dry granulation is involved. 
Direct compression represents the simplest and most cost 
effective tablet manufacturing technique. This technique 
can now be applied to preparation of fast dissolving tablets 
because of the availability of improved excipients 
especially superdisintegrants and sugar based excipients. 
Direct compression, using directly compressible excipients 
is the most commonly used method of preparing fast 
dissolving tablets. Directly compressible excipients are 
very coarse and granular in nature and give a coarse 
dispersion in the mouth with decreased mouth feel and 
compliance. It is very difficult to prepare fast dissolving 
tablets with drugs having very low bulk density, higher 
dose and poor flow property using this technique.  
 (a) Superdisintegrants: 
In many orally disintegrating tablet technologies based on 
direct compression, the addition of superdisintegrants 
principally affects the rate of disintegration and hence the 
dissolution. The presence of other formulation ingredients 
such as water-soluble excipients and effervescent agents 
further hastens the process of disintegration. This 
technique contains coated crystals and micro granules 
along with the disintegrants. In this technology, two types 
of granules are used; a disintegrating agent (e.g. modified 
cellulose- croscarmellose sodium), which has a high 
swelling force, and a swelling agent (e.g. starch), which 
has a low swelling force. 
Other techniques like effervescent tablets in which 
disintegration is aided by evolution of carbon dioxide. 
Saliva activates the effervescent agent, causing the tablet 
to disintegrate. Care should be observed because 
effervescent excipients and final product require higher 
protection against humidity conditions.  
 (b) Sugar Based Excipients: 
This is another approach to manufacture fast dissolving 
tablets by direct compression. The use of sugar based 
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excipients especially bulking agents like dextrose, 
fructose, isomalt, lactilol, lactose, maltilol, maltose, 
mannitol, sorbitol, starch hydrolysate, polydextrose and 
xylitol, which display high aqueous solubility and 
sweetness, and hence impart taste masking property and a 
pleasing mouth feel. 
These excipients under defined manufacturing conditions 
gives a highly porous structure and friable exterior 
structure which helps in faster disintegration of fast 
dissolving tablets, they also provide a satisfactory mouth 
feel and so suitable for use in preparation of harder fast 
dissolving tablets by direct compression at low pressure.  
There was no much attention to the direct compression of 
pharmaceuticals in the previous days (late 1950s). Now a 
days great deal of attention has been given to both product 
and process development. The availability of new 
materials, new forms of old materials and the invention of 
new machinery has allowed the production of tablets by 
simplified and reliable methods. In early 1960‟s, the 
introduction of spray dried lactose (1960) and avicel 
(1964) had changed the tablet manufacturing process and 
opened avenues of direct compression tableting. 
Previously, the word direct compression was used to 
identify the compression of a single crystalline compound 
(i.e. sodium chloride, potassium chloride, potassium 
bromide, etc.) into a compact form without the addition of 
other substances. Current usage of the term direct 
compression is used to define the process by which tablets 
are compressed directly from the powder blends of active 
ingredient/s and suitable excipients. No pre-treatment of 
the powder blends by wet or dry granulation is involved. 
 6. Dry granulation technique:  The fast dissolving 
tablets has been prepared by means of dry granulation 
technology, which has the following advantages over other 
techniques of preparation:  
 1. It can be used for all types of drugs including moisture 
sensitive and heat sensitive.  
 2. It can be used for drugs having very low bulk density  
 3. It can be used for poorly compressible drugs and drugs 
having poor flow property. 
 4. The tablets can be packed into regular bottles, blister, 
strip pack or sachets.  
5. The tablets can be stored in bulk in drums to be 
packaged subsequently. Moreover conventional tablet 
packaging feeders can be used for packing purpose. The 
process of dry granulation is cost effective as it avoids 
solvents, and the processes of drying like freeze drying, 
spray drying etc.  
6. This reduces overall reduction in capital expenditure 
(conventional processing, packaging, and storage 
facilities). These dosage forms may be in the form of 
tablets, wafers, granules, or granules packed as such along 
with other pharmaceutically acceptable additives in a 
suitable package which upon contact with water, saliva or 
aqueous solution disintegrates within a few seconds. 
7. Cotton Candy Process:  
The cotton candy process is also known as the “candy 
floss” process and forms the basis of the technologies such 
as Flash Dose (Fuisz Technology). A fast dissolving 
tablets is formed using a candyfloss or shear form matrix; 
the matrix is formed from saccharides or polysaccharides 
processed into amorphous floss by a simultaneous action 
of flash melting and centrifugal force. The matrix is then 
cured or partially recrystallised to provide a compound 
with good flow properties and compressibility. The 
candyfloss can then be milled and blended with active 
ingredients and other excipients and subsequently 
compressed into fast dissolving tablets. However the high 
processing temperature limits the use of this technology to 
thermo stable compounds only. 
8. Mass Extrusion
5
: This technology involves softening 
the active blend using the solvent mixture of water-soluble 
polyethylene glycol and methanol and subsequent 
expulsion of softened mass through the extruder or syringe 
to get a cylinder of the product into even segments using 
heated blade to form tablets. The dried cylinder can also be 
used to coat granules for bitter drugs and thereby achieve 
taste masking. 
NEW ORALLY DISINTIGRATING DOSAGE 
FORMS
6
: 
Oral films and wafers: 
Oral films and wafers are the newer technologies in the 
manufacturing of orally disintegrating dosage forms. They 
are thin elegant films of edible water-soluble polymers of 
various sizes and shapes like square, rectangle or disc. The 
strips may be flexible or brittle, opaque or transparent. 
They are designed to provide rapid disintegration on the 
tongue without the need for water. They have the 
advantage of a large specific surface area for 
disintegration. One or a combination of the following 
processes like hot-melt extrusion; solid dispersion 
extrusion, rolling and solvent casting are used to 
manufacture these films. A major limitation of these 
dosage forms is low drug loading capacity and limited 
taste masking option.  
ZYDIS (R.P. Scherer, Inc.): 
Zydis, the best known of the fast-dissolving/disintegrating 
tablet preparations, was the first marketed new technology 
tablet. The tablet dissolves in the mouth within seconds 
after placement on the tongue. A Zydis tablet is produced 
by lyophilizing or freeze-drying the drug in a matrix 
usually consisting of gelatin. The product is very 
lightweight and fragile, and must be dispensed in a special 
blister pack. Patients should be advised not to push the 
tablets through the foil film, but instead peel the film back 
to release the tablet. The Zydis product is made to dissolve 
on the tongue in 2 to 3 seconds. The Zydis formulation is 
also self-preserving because the final water concentration 
in the freeze-dried product is too low to allow for 
microbial growth. The Zydis formulation utilizes flavors 
and sweeteners to optimize the taste of the dosage form. In 
addition, it utilizes microencapsulation with specialized 
polymers or complexation with ion exchange resins to 
mask the bitter tasting drug. The combination of 
lyophilization and taste masking creates a product that is 
both pleasing to the eye and also to the senses of taste and 
touch. A major claim of the Zydis product is increased 
bioavailability compared to traditional tablets. Because of 
its dispersion and dissolution in saliva while still in the 
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oral cavity, there can be a substantial amount of pregastric 
absorption from this formulation. Buccal, pharyngeal and 
gastric regions are all areas of absorption of the Zydis 
formulation. Any pre-gastric absorption avoids first-pass 
metabolism and can be an advantage in drugs that undergo 
a great deal of hepatic metabolism. However, if the amount 
of swallowed drug varies, there is the potential for 
inconsistent bioavailability. While the claimed increase in 
bioavailability is debatable, it is clear that the major 
advantage of the Zydis formulation is convenience.  
There are some disadvantages to the Zydis technology. 
The process of freeze-drying is a relatively expensive 
manufacturing process. As mentioned earlier, the Zydis 
formulation is very lightweight and fragile, and therefore 
should not be stored in backpacks or the bottom of purses. 
Finally, the Zydis formulation has poor stability at higher 
temperatures and humidities. It readily absorbs water, and 
is very sensitive to degradation at humidities greater than 
65%. If there is any pinhole or minor damage to the 
package, the patient may find the lyophilized product has 
collapsed due to absorption of moisture. As with most 
other drugs, patients should be advised to avoid storing the 
Zydis technology in the medicine cabinet in the bathroom. 
Patients should use their Zydis formulation within six 
months of opening the laminated foil pouch and 
immediately after opening its individual blister packaging.
 
Table1: List of Patented Technologies using manufacturing techniques and description 
Technology Basis for technology Company 
Zydis Lyophilization R. P. Scherer Inc. 
Quicksolv Lyophilization Janseen Pharmaceutical 
Lyoc Lyophilization Farmlyoc 
Flashtab 
Multiparticulate Compressed 
Tablets 
Ethypharm 
Orasolv, Durasolv Compressed Tablets Cima Labs Inc. 
Rapitab Compressed Tablets Schwarz Pharma 
Wowtab Compressed Molded Tablets 
Yamanouchi 
PharmaTechnologies, Inc. 
Fastmelt Molding Élan Corp. 
Ziplets Molding Eurand 
Flashdose Cotton-candy process Fuisz Technology Ltd. 
 
 
ORASOLV (Cima Labs, Inc.): 
 Orasolv was Cima's first fast-dissolving/disintegrating 
dosage form. The Orasolv technology, unlike Zydis, 
disperses in the saliva with the aid of almost imperceptible 
effervescence. The Orasolv technology is best described as 
a fast-dissolving tablet; the tablet matrix dissolves in less 
than one minute, leaving coated drug powder. The taste 
masking associated with the Orasolv formulation is two-
fold. The unpleasant flavor of a drug is not merely 
counteracted by sweeteners or flavors; both coating the 
drug powder and effervescence are means of taste masking 
in Orasolv. This technology is frequently used to develop 
over-the-counter formulations. The major disadvantage of 
the Orasolv formulations is its mechanical strength. The 
Orasolv tablet has the appearance of a traditional 
compressed tablet. However, the Orasolv tablets are only 
lightly compressed, yielding a weaker and more brittle 
tablet in comparison with conventional tablets. For that 
reason, Cima developed a special handling and packaging 
system for Orasolv. An advantage that goes along with the 
low degree of compaction of Orasolv is that the particle 
coating used for taste masking is not compromised by 
fracture during processing. Lyophilization and high 
degrees of compression, as utilized in Orasolv primary 
competitors, may disrupt such a taste masking approach.  
DURASOLV (Cima Labs, Inc.): 
Durasolv is Cima's second-generation fast-
dissolving/disintegrating tablet formulation. Produced in a 
fashion similar to Orasolv, Durasolv has much higher 
mechanical strength than its predecessor due to the use of 
higher compaction pressures during tableting. The 
Durasolv product is thus produced in a faster and more 
cost-effective manner. Durasolv is so durable that it can be 
packaged in either traditional blister packaging or vials. 
The newest Durasolv formulation, NuLev, is actually 
dispensed in a conventional stock bottle. Pharmacists are 
advised to take care when dispensing such Durasolv 
formulations from stock bottles to ensure they are not 
exposed to high levels of moisture or humidity. Excess 
handling of tablets can introduce enough moisture to 
initiate dissolution of the tablet matrix. One disadvantage 
of Durasolv is that the technology is not compatible with 
larger doses of active ingredients, because the formulation 
is subjected to such high pressures on compaction. Unlike 
Orasolv, the structural integrity of any taste masking may 
be compromised with high drug doses. The drug powder 
coating in Durasolv may become fractured during 
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compaction, exposing the bitter-tasting drug to a patient's 
taste buds. Therefore, the Durasolv technology is best 
suited for formulations including relatively small doses of 
active compound.  
WOWTAB (Yamanouchi Pharma Technologies, Inc.):
 
 
The WOWTAB fast-dissolving/disintegrating tablet 
formulation has been on the Japanese market for a number 
of years. It has just recently been introduced into the U.S. 
The WOWTAB technology utilizes sugar and sugar-like 
(e.g., mannitol) excipients. The two different types of 
saccharides are combined to obtain a tablet formulation 
with adequate hardness and fast dissolution rate. Due to its 
significant hardness, the WOWTAB formulation is a bit 
more stable to the environment than the Zydis or Orasolv. 
It is suitable for both conventional bottle and blister 
packaging. The taste masking technology utilized in the 
WOWTAB is proprietary, but claims to offer superior 
mouth feel due to the patented SMOOTHMELT action. 
The WOWTAB product dissolves quickly in 15 seconds or 
less. The WOW in WOWTAB signifies the tablet is to be 
given Without Water. Two WOWTAB formulations 
currently on the U.S. market are Benadryl Allergy and 
Sinus FASTMELT and Children's Benadryl Allergy and 
Cold FASTMELT.  
OTHER TECHNOLOGIES: 
Flash Dose (Fuisz Technologies), Flashtab (Prographarm 
Group), and OraQuick (KV Pharmaceutical Co., Inc.) are 
three formulations on the worldwide market. Biovail Corp. 
recently announced the filing of an NDA for a FlashDose 
version of zolpidem tartrate. These technologies are 
similar to Zydis, WOWTAB, Orasolv and Durasolv in that 
they dissolve or disperse on the tongue within a minute. 
However, each also has unique characteristics to 
differentiate itself from the competition.  
FLASHDOSE (Fuisz Technologies, Ltd.):  Fuisz 
Technologies has three oral drug delivery systems that are 
related to fast dissolution. The first two generations of 
quick-dissolving tablets, Soft Chew and EZ Chew, require 
some chewing. However, these paved the way for Fuisz's 
most recent development, FlashDose. The FlashDose 
technology utilizes a unique spinning mechanism to 
produce a floss-like crystalline structure, much like cotton 
candy. This crystalline sugar can then incorporate the 
active drug and be compressed into a tablet. This 
procedure has been patented by Fuisz and is known as 
Shearform. The final product has a very high surface area 
for dissolution. It disperses and dissolves quickly once 
placed onto the tongue. Interestingly, by changing the 
temperature and other conditions during production, the 
characteristics of the product can be altered greatly. 
Instead of a floss-like material, small spheres of 
saccharides can be produced to carry the drug. The process 
of making microspheres has been patented by Fuisz, and is 
known as CEFORM1 and serves as an alternative method 
of taste masking.  
FLASHTAB (Prographarm Group): The Flashtab 
technology is yet another fast-dissolving/disintegrating 
oral tablet formulation. It utilizes most of the same 
excipients as in conventional compressed tablets. A 
disintegrating agent and a swelling agent are used in 
combination with coated drug particles in this formulation 
to produce a tablet that disintegrates in the mouth in less 
than one minute.  
ORAQUICK (KV Pharmaceutical Co., Inc.): 
The OraQuick fast-dissolving/disintegrating tablet 
formulation utilizes a patented taste masking technology. 
KV Pharmaceutical claims its microsphere technology, 
known as Micro Mask, has superior mouth feel over taste-
masking alternatives. The taste masking process does not 
utilize solvents of any kind, and therefore leads to faster 
and more efficient production. Also, lower heat of 
production than alternative fast-dissolving/disintegrating 
technologies makes OraQuick appropriate for heat-
sensitive drugs. KV Pharmaceutical also claims that the 
matrix that surrounds and protects the drug powder in 
microencapsulated particles is more pliable, meaning 
tablets can be compressed to achieve significant 
mechanical strength without disrupting taste masking. 
OraQuick claims quick dissolution in a matter of seconds, 
with good taste masking. 
1.3 TASTE MASKING WITH ION EXCHANGE 
RESIN  
   Drug can be bound to the resin by either repeated 
exposure of the resin to the drug in a chromatographic 
column or by prolonged contact of resin with the drug 
solution. The resin forms insoluble adsorbates or resonates 
through weak ionic bonding with oppositely charged 
drugs. The exchange from counter ions from the resin is 
competitive. 
   Drug release from the resin depends on the two factors: 
  1. The ionic environment (i.e., pH and electrolyte 
concentration ) within the gastrointestinal    tract  
  2.  The properties of the resin. 
  Drug molecules attached to the resin are released by 
exchanging with appropriately charged ions in the 
gastrointestinal tract, followed by diffusion of free drug 
molecule out of the resins. The process can be depicted by 
the following equation 1 and 2 for anion exchange and 
cation exchange respectively. Where x and y are ions in 
the GI tract.  
Resin+ -- Drug-  + x-    resin+-- x- + drug -                   ….1 
Resin- -- Drug+  + y+    resin--- y+ + drug +  ….2
 
Table 4: Flavouring agents used for taste masking 
Basic Taste                                          Masking agents 
Sweet Vanilla, Bubble gum, Grapefruit 
Acid Lemon, Lime, Orange, Cherry, Grapefruit 
Metallic Grape, Marsh, Mellow, Gurana, Berries, Mints 
Bitter Liquorice, Coffee, Chocolate, Mint, Grapefruit,Cherry, Peach, Raspberry, Orange, Lemon, Lime. 
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1.5 POLYMERS USED FOR TASTE MASKING BY COATING
  
A number of coating materials such as hydrophilic polymers, lipophillic polymers, celluloses, carbohydrates, etc are 
employed for taste masking. 
Table 3: Polymers used for Taste Masking 
Bitter drugs Polymer used 
Artemether Eudragit E 100 
Valdecoxib Eudragit EPO and hydroxypropylmethylcellulose 
Pinaverium bromide Cellulose or shellac 
Propantheline bromide L-HPC,EC 
Ibuprofen Methacrylic acid co-polymer(Eudragit) 
Triprolidine HCL HPMC 
Cefeanel daloxate HCL PVP,EC,HPMC 
Enoxacin HPMC,HPC,EC 
Sparfloxacin HPMC,HPC,EC, L-HPC 
Aspirin Cellulose acetate latex and triacetine 
Famotidine HEC,HPMC 
Amoxicillin trihydrate MCC,L-HPC 
Acetaminophen Cellulose acetate,HPC/cellulose acetate,Eudragit E100,PVP 
Amiprilose HCL Calcium gluconate, Calcium alginate 
Clarithromycine Carbopol,PVP 
Drugx PEG,EudragitL 100-55 
Nizatidine Eudragit E 100 
Cetraxate HCL Corn starch,Macrogol-6000 
Ciprofloxacin Eudragit NE30 D 
Pirenzepine and Oxybutynin Eudragit E-100,MCC, HPC 
 
Disadvantage: 
 The coating of fine particles is usually unsuccessful and 
Coating of granular particles is readily ruptured by 
chewing and compression.  
 Coating with polymers requires sophisticated 
instruments.  
 In addition, most coatings don not have an acceptable 
in vivo drug releasing mechanism. 
Table 5: Taste masking of Drugx with Taste masking Agent 
Bitter drugs Taste masking agent Taste masking approach 
Drugx        Kyron Complexation 
 
5.4 Physico-mechanical characterization 
5.4.1 Bulk Density: 
It refers to packing of particles. Bulk density is used to 
determine the amount of drug that occupies the volume in 
g/ml. 
Procedure: Weighed quantity (10gm) of Drug X was 
transferred into 100 ml measuring cylinder without tapping 
during transfer. The volume occupied by drug was 
measured. Bulk density was measured by using formula 
                                                       ρi   = m /Vi 
                    Where, m   = mass of the blend 
             Vi   = untapped volume 
Tapped density:  
Weighed quantity (10gm) of drug was taken into a 
graduated cylinder. Volume occupied by the drug was 
noted down. Then the cylinder was subjected to 500, 750 
&1250 taps in tap density apparatus (Electro Lab USP II). 
According to USP, The blend was subjected for 500 taps. 
% Volume variation was calculated and subjected for 
additional 750 taps. % Variation is calculated. 
                                  ρt = m/Vt 
Where, Vt is tapped volume 
5.4.3 Carr’s Index (Compressibility):  
The compressibility index and Hausner ratio are measures 
of the property of powder to be compressed. The packing 
ability of drug was evaluated from change in volume, 
which is due to rearrangement of packing occurring during 
tapping. It was indicated as Carr‟s compressibility index 
was calculated as follows. 
Carr’s index = [Tapped density - Bulk density/Tapped 
density] X 100 
5.4.4  Hausner Ratio: It is measurement of frictional 
resistance of the drug .The ideal range should be 1.2-1.5. It 
was determined by the ratio of tapped density and bulk 
density 
Hausner Ratio = Tapped density / Bulk density 
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5.4.5  Angle of Repose: 
It is defined as the maximum angle that can be obtained 
between the free standing of powder heap and horizontal 
plane, which is given by the equation: 
 = tan-1 h/r 
Where,     = Angle of repose. 
              h   = Height of powder heap.  
              r   = Radius of the powder cone. 
 
 
CONCLUSION:  
The objective of formulation development and evaluation 
of fast disintegrating tablets of Drugx was being achieved. 
The effective taste masking was achieved for Drugx by 
preparation of granules using Dushion P544 (R). These 
patient compliant tablets that had a good taste and rapidly 
disintegrated in the mouth are useful and practical for 
pediatric and geriatric formulation. Thus, we are able to 
achieve our objective of preparing FDTs of Drugx to 
increase its dissolution by its faster disintegration. 
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